Marizyme Inc.

09/22/2021 | Press release | Distributed by Public on 09/22/2021 15:22

Submission of Matters to a Vote of Security Holders (Form 8-K)

Submission of Matters to a Vote of Security Holders

On September 20, 2021, Marizyme, Inc. (the "Company") held its Annual Meeting of Shareholders virtually via live audio webcast at https://agm.issuerdirect.com/mrzm. A total of 23,184,747 shares of common stock representing 64.53% of the aggregate shares outstanding and eligible to vote and constituting a quorum were represented in person or by valid proxies at the annual meeting.

Terry Brostowin, Esq., Dr. William Hearl, Julie Kampf, and Dr. Vithalbhai Dhaduk were each elected as directors of the Company to serve until the next annual meeting of shareholders.

The shareholders ratified the Company's Amended and Restated 2021 Stock Incentive Plan.

The shareholders voted in favor of the non-binding advisory proposal that the compensation of the Company's named executive officers as disclosed in the Company's Proxy Statement for its 2021 Annual Meeting of Shareholders, pursuant to Item 402(m) through (q) of Regulation S-K, including the compensation tables and narrative discussion, be approved.

The final voting results on these matters were as follows:

1. Election of Directors:

Name Votes For Votes Withheld Broker Non-Votes
Terry Brostowin, Esq. 23,097,778 86,969 N/A
Dr. William Hearl 23,097,778 86,969 N/A
Julie Kampf 20,538,838 2,645,909 N/A
Dr. Vithalbhai Dhaduk 20,754,078 2,430,669 N/A

2. Ratification of the Company's Amended and Restated 2021 Stock Incentive Plan:

Votes For Votes Against Votes Abstained Broker Non-Votes
21,702,790 1,406,197 75,760 N/A

3. Non-Binding Advisory Vote on Executive Compensation set forth in the Company's Proxy Statement Summary Executive Compensation Table:

Votes For Votes Against Votes Abstained Broker Non-Votes
21,372,984 1,446,207 365,556 N/A